These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 34021237)

  • 21. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
    Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
    Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 Spike Antagonizes Innate Antiviral Immunity by Targeting Interferon Regulatory Factor 3.
    Freitas RS; Crum TF; Parvatiyar K
    Front Cell Infect Microbiol; 2021; 11():789462. PubMed ID: 35083167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63.
    Saletti G; Gerlach T; Jansen JM; Molle A; Elbahesh H; Ludlow M; Li W; Bosch BJ; Osterhaus ADME; Rimmelzwaan GF
    Sci Rep; 2020 Dec; 10(1):21447. PubMed ID: 33293664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The low abundance of CpG in the SARS-CoV-2 genome is not an evolutionarily signature of ZAP.
    Afrasiabi A; Alinejad-Rokny H; Khosh A; Rahnama M; Lovell N; Xu Z; Ebrahimi D
    Sci Rep; 2022 Feb; 12(1):2420. PubMed ID: 35165300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
    Braun J; Loyal L; Frentsch M; Wendisch D; Georg P; Kurth F; Hippenstiel S; Dingeldey M; Kruse B; Fauchere F; Baysal E; Mangold M; Henze L; Lauster R; Mall MA; Beyer K; Röhmel J; Voigt S; Schmitz J; Miltenyi S; Demuth I; Müller MA; Hocke A; Witzenrath M; Suttorp N; Kern F; Reimer U; Wenschuh H; Drosten C; Corman VM; Giesecke-Thiel C; Sander LE; Thiel A
    Nature; 2020 Nov; 587(7833):270-274. PubMed ID: 32726801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Slowing Rate of CpG Depletion in SARS-CoV-2 Genomes Is Consistent with Adaptations to the Human Host.
    Kumar A; Goyal N; Saranathan N; Dhamija S; Saraswat S; Menon MB; Vivekanandan P
    Mol Biol Evol; 2022 Mar; 39(3):. PubMed ID: 35134218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
    Messina F; Giombini E; Agrati C; Vairo F; Ascoli Bartoli T; Al Moghazi S; Piacentini M; Locatelli F; Kobinger G; Maeurer M; Zumla A; Capobianchi MR; Lauria FN; Ippolito G;
    J Transl Med; 2020 Jun; 18(1):233. PubMed ID: 32522207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coding potential and sequence conservation of SARS-CoV-2 and related animal viruses.
    Cagliani R; Forni D; Clerici M; Sironi M
    Infect Genet Evol; 2020 Sep; 83():104353. PubMed ID: 32387562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.
    Xu W; Wang M; Yu D; Zhang X
    Front Immunol; 2020; 11():565278. PubMed ID: 33013929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens.
    Vashi Y; Jagrit V; Kumar S
    Infect Genet Evol; 2020 Oct; 84():104382. PubMed ID: 32473352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytosine deamination and selection of CpG suppressed clones are the two major independent biological forces that shape codon usage bias in coronaviruses.
    Woo PC; Wong BH; Huang Y; Lau SK; Yuen KY
    Virology; 2007 Dec; 369(2):431-42. PubMed ID: 17881030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-Wide Analysis of Codon Usage Patterns of SARS-CoV-2 Virus Reveals Global Heterogeneity of COVID-19.
    Khattak S; Rauf MA; Zaman Q; Ali Y; Fatima S; Muhammad P; Li T; Khan HA; Khan AA; Ngowi EE; Wu DD; Ji XY
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Putative long-range RNA-RNA interaction between ORF8 and Spike of SARS-CoV-2.
    Omoru OB; Pereira F; Janga SC; Manzourolajdad A
    PLoS One; 2022; 17(9):e0260331. PubMed ID: 36048827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of 3.5 million SARS-CoV-2 sequences reveals unique mutational trends with consistent nucleotide and codon frequencies.
    Fumagalli SE; Padhiar NH; Meyer D; Katneni U; Bar H; DiCuccio M; Komar AA; Kimchi-Sarfaty C
    Virol J; 2023 Feb; 20(1):31. PubMed ID: 36812119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The heterogeneous landscape and early evolution of pathogen-associated CpG dinucleotides in SARS-CoV-2.
    Di Gioacchino A; Šulc P; Komarova AV; Greenbaum BD; Monasson R; Cocco S
    bioRxiv; 2020 Dec; ():. PubMed ID: 32511407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Codon Usage and Phenotypic Divergences of SARS-CoV-2 Genes.
    Dilucca M; Forcelloni S; Georgakilas AG; Giansanti A; Pavlopoulou A
    Viruses; 2020 Apr; 12(5):. PubMed ID: 32366025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection.
    Li N; Hui H; Bray B; Gonzalez GM; Zeller M; Anderson KG; Knight R; Smith D; Wang Y; Carlin AF; Rana TM
    Cell Rep; 2021 May; 35(6):109091. PubMed ID: 33961823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability in Codon Usage in Coronaviruses Is Mainly Driven by Mutational Bias and Selective Constraints on CpG Dinucleotide.
    Daron J; Bravo IG
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Heterogeneous Landscape and Early Evolution of Pathogen-Associated CpG Dinucleotides in SARS-CoV-2.
    Di Gioacchino A; Šulc P; Komarova AV; Greenbaum BD; Monasson R; Cocco S
    SSRN; 2020 May; ():3611280. PubMed ID: 32714120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Silico Prediction and Selection of Target Sequences in the SARS-CoV-2 RNA Genome for an Antiviral Attack.
    Hussein M; Andrade Dos Ramos Z; Berkhout B; Herrera-Carrillo E
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.